MGMT and glioblastoma: The urgent need for new treatments for GBM that may come from drug repurposing is shown by the fact that TMZ only increased median survival by 2 months, MGMT promoter unmethylated patients are much less sensitive to the drug, and rapid tumor recurrence often occurs [63, 64].